Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.90149
Publication URI: https://www.repository.cam.ac.uk/handle/1810/342736
Type: Journal Article/Review